It was a moment of great pride when Pune’s prestigious Eye hospital, K K Eye Institute was honoured with the “Pride of Maharashtra” Award in the category of the “Best Eye Hospital” at the Leadership Awards held at Pride Hotel in Pune, recently. The K K Eye Institute places top on its priority – the aspect of patient care and ethical medical practices.
The team comprises of eye doctors who are surgeons par excellence, committed to the Institute on a full time basis. They are specialized in different fields of eye care that aim to provide better sight for all age groups from children, to the young, to adults and the elderly.
With its facilities spread over 40000 sq feet of space at Koregaon Park, this eye hospital encompasses diagnosis and treatment of eye care ranging from simple spectacle powers, cataract surgeries to more complex retinal and cornea problems.
“What gives me deep happiness is that out of the one lakh and twenty thousand cataract surgeries we have performed, the many thousands of procedures and investigations carried out, the lakhs of consultations done, we stand tall in the fact that not a single one has been unwarranted and unnecessary!” beamed the CEO, Ms. Renu Wadhwa, while accepting the award.
With a progressive vision of eye care, exceptional spirit of service and transparency, leading edge equipment and expert eye specialists, the K K Eye Institute has been moving ahead steadily on the pathway of a “quality with integrity” ideology.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!
Notify me of follow-up comments by email.
Notify me of new posts by email.
President Williams on the Economy in the Time of Coronavirus
3 esteemed officers of Indian Territorial Army come forward to distribute essential kits to sex workers and transgenders
Startup Solutions for Corona Problems
3 Reasons Why Live Casino Games Are Dominating the Industry
Glenmark to commence another new Phase 3 clinical trial on a combination of two antiviral drugs
2014 The Global Indian New Network (TGINN)